Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$9.19 USD
-0.20 (-2.13%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $9.21 +0.02 (0.22%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-1.30 | 0.00% |
Earnings Summary
For their last quarter, Adverum Biotechnologies (ADVM) reported earnings of -$2.30 per share, beating the Zacks Consensus Estimate of $-2.80 per share. This reflects a positive earnings surprise of 17.86%. Look out for ADVM's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$1.30 per share, reflecting a year-over-year increase of 55.17%.
Earnings History
Price & Consensus
Zacks News for ADVM
Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services